We are live on ! Find out more
KXA

KPCB XII Associates Portfolio holdings

AUM $738K
1-Year Est. Return 3.15%
This Fund
S&P 500
This Quarter Est. Return
+20.15%
1 Year Est. Return
-3.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$30.2M
AUM Growth
-$21.2M
Cap. Flow
-$26M
Cap. Flow %
-86.26%
Top 10 Hldgs %
100%
Holding
3
New
Increased
Reduced
Closed
1

Top Buys

No buys this quarter

Top Sells

Rank Stock Value
1
CBLK
Carbon Black, Inc. Common Stock
CBLK
+$26M

Sector Composition

Rank Sector Weight
1 Healthcare 97.41%
2 Materials 2.59%
3 Technology 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INSP icon
1
Inspire Medical Systems
INSP
$1.46B
$29.4M 97.41%
396,406
AMRS
2
DELISTED
Amyris Inc.
AMRS
$781K 2.59%
252,834
CBLK
3
DELISTED
Carbon Black, Inc. Common Stock
CBLK
-1,002,253
Closed -$26M

Similar funds

KPCB XII Associates's Q4 2019 Portfolio in Review

As of Q4 2019, KPCB XII Associates held 3 positions worth $30.2M, down 41% from $51.4M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

KPCB XII Associates withdrew a net $26M in Q4 2019, closing 1 position. Its most notable exit was Carbon Black, Inc. Common Stock, an estimated $26M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 97% of assets, up from 47% a quarter earlier, followed by Materials and Technology.

  • KPCB XII Associates fully exited Carbon Black, Inc. Common Stock in Q4 2019, selling an estimated $26M.
  • KPCB XII Associates's ten largest holdings make up 100% of its $30.2M portfolio in Q4 2019.
  • KPCB XII Associates opened 0 new positions and closed 1 in Q4 2019.
  • KPCB XII Associates's portfolio value fell 41% quarter-over-quarter to $30.2M.

Based on KPCB XII Associates's 13F filing for Q4 2019, filed 13 Feb 2020.